PL2939665T3 - Kompozycja farmaceutyczna do leczenia zakażeń hiv - Google Patents

Kompozycja farmaceutyczna do leczenia zakażeń hiv

Info

Publication number
PL2939665T3
PL2939665T3 PL13867546T PL13867546T PL2939665T3 PL 2939665 T3 PL2939665 T3 PL 2939665T3 PL 13867546 T PL13867546 T PL 13867546T PL 13867546 T PL13867546 T PL 13867546T PL 2939665 T3 PL2939665 T3 PL 2939665T3
Authority
PL
Poland
Prior art keywords
treatment
pharmaceutical composition
hiv infections
hiv
infections
Prior art date
Application number
PL13867546T
Other languages
English (en)
Inventor
Vikram Singkh PUNIYA
Gennady Andreevich Batyunin
Natalya Yurievna MALYKH
Original Assignee
Aktsionernoe Obschestvo "Farmasyntez"
Vikram Singkh PUNIYA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49957619&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2939665(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aktsionernoe Obschestvo "Farmasyntez", Vikram Singkh PUNIYA filed Critical Aktsionernoe Obschestvo "Farmasyntez"
Publication of PL2939665T3 publication Critical patent/PL2939665T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PL13867546T 2012-12-29 2013-09-19 Kompozycja farmaceutyczna do leczenia zakażeń hiv PL2939665T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012158141/15A RU2505286C1 (ru) 2012-12-29 2012-12-29 Фармацевтическая композиция для лечения вич-инфекции, способ ее получения и способ лечения
EP13867546.7A EP2939665B1 (en) 2012-12-29 2013-09-19 Pharmaceutical composition for treatment of hiv infections
PCT/RU2013/000817 WO2014104929A1 (ru) 2012-12-29 2013-09-19 Фармацевтическая композиция для лечения вич-инфекции

Publications (1)

Publication Number Publication Date
PL2939665T3 true PL2939665T3 (pl) 2020-01-31

Family

ID=49957619

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13867546T PL2939665T3 (pl) 2012-12-29 2013-09-19 Kompozycja farmaceutyczna do leczenia zakażeń hiv

Country Status (18)

Country Link
US (1) US10493034B2 (pl)
EP (1) EP2939665B1 (pl)
CN (1) CN104884050A (pl)
CA (1) CA2896710C (pl)
CY (1) CY1121660T1 (pl)
DK (1) DK2939665T3 (pl)
EA (1) EA029586B1 (pl)
ES (1) ES2729568T3 (pl)
HR (1) HRP20190882T1 (pl)
HU (1) HUE043694T2 (pl)
LT (1) LT2939665T (pl)
PL (1) PL2939665T3 (pl)
PT (1) PT2939665T (pl)
RS (1) RS58837B1 (pl)
RU (1) RU2505286C1 (pl)
SI (1) SI2939665T1 (pl)
TR (1) TR201908007T4 (pl)
WO (1) WO2014104929A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105194687A (zh) * 2015-10-22 2015-12-30 浙江医药高等专科学校 沙喹那韦或其甲磺酸盐的环糊精包合物制备方法
WO2017086835A1 (ru) * 2015-11-17 2017-05-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты)
RU2616267C1 (ru) * 2016-01-25 2017-04-13 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма индинавира немедленного высвобождения и способ ее получения
CN117500923A (zh) 2021-04-07 2024-02-02 巴特尔纪念研究院 用于鉴定和使用非病毒载体的快速设计、构建、测试和学习技术
WO2024085784A1 (ru) * 2022-10-19 2024-04-25 Общество С Ограниченной Ответственностью "Промомед Рус" Фармацевтическая композиция и лекарственное средство для лечения коронавирусной инфекции
WO2024091148A2 (ru) * 2022-10-26 2024-05-02 Общество С Ограниченной Ответственностью "Абицея Медикал Технолоджис" Жидкий бальнеологический концентрат и ампула с мерной шкалой и устройством для удобного дозирования бальнеологического концентрата

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US20050048112A1 (en) * 2003-08-28 2005-03-03 Jorg Breitenbach Solid pharmaceutical dosage form
CA2660374A1 (en) * 2006-08-10 2008-02-14 Cipla Limited Antiretroviral solid oral composition
PA8809601A1 (es) * 2007-12-24 2009-07-23 Cipla Ltd Combinación anti-retroviral
JP2011509283A (ja) * 2008-01-11 2011-03-24 シプラ・リミテッド 固体医薬剤形
WO2010006050A1 (en) * 2008-07-09 2010-01-14 Purdue Research Foundation Hiv protease inhibitors and methods for using
US20110034489A1 (en) * 2009-07-31 2011-02-10 Ranbaxy Laboratories Limited Solid dosage forms of hiv protease inhibitors
EP2714683A4 (en) * 2011-05-27 2014-11-05 Hetero Research Foundation RITONAVIR AMORPH CO-PRECIPITATION
US20150004237A1 (en) * 2012-01-09 2015-01-01 Virginia Tech Intellectual Properties, Inc. Cellulose derivatives for inhibiting crystallization of poorly water-soluble drugs
US20150045400A1 (en) * 2012-03-01 2015-02-12 Bandi Parthasaradhi Reddy Ritonavir compositions
WO2014184553A1 (en) * 2013-05-15 2014-11-20 Cipla Limited Pharmaceutical antiretroviral compositions

Also Published As

Publication number Publication date
EA201500710A1 (ru) 2015-10-30
WO2014104929A1 (ru) 2014-07-03
PT2939665T (pt) 2019-06-14
DK2939665T3 (da) 2019-06-11
EA029586B1 (ru) 2018-04-30
HRP20190882T1 (hr) 2019-09-20
LT2939665T (lt) 2019-07-25
US20150297526A1 (en) 2015-10-22
SI2939665T1 (sl) 2019-08-30
CA2896710C (en) 2019-03-26
TR201908007T4 (tr) 2019-06-21
RS58837B1 (sr) 2019-07-31
EP2939665A1 (en) 2015-11-04
HUE043694T2 (hu) 2019-09-30
EP2939665A4 (en) 2016-06-01
CA2896710A1 (en) 2014-07-03
CY1121660T1 (el) 2020-07-31
ES2729568T3 (es) 2019-11-04
CN104884050A (zh) 2015-09-02
RU2505286C1 (ru) 2014-01-27
EP2939665B1 (en) 2019-03-20
US10493034B2 (en) 2019-12-03

Similar Documents

Publication Publication Date Title
HK1211589A1 (en) Compounds for the treatment of paramoxyvirus viral infections
HK1212632A1 (zh) 用於治療 介導的疾病的藥物組合物
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PT2818482T (pt) Composição farmacêutica para o tratamento de cancro
HUE045461T2 (hu) Gyógyászati készítmény rák kezelésére
SI2854768T1 (sl) Farmacevtski sestavki pemetrekseda
HK1206623A1 (en) Pharmaceutical compositions and treatment of mastitis
HK1208378A1 (en) Pharmaceutical composition for the treatment of fungal infections
PT3524260T (pt) Composições farmacêuticas para o tratamento de inapetência
EP2939665A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HIV INFECTIONS
ZA201502695B (en) Stable pharmaceutical composition of peginterferon alpha-2b
HUP1200552A2 (en) Pharmaceutical compositions for the treatment of high blood pressure
SI2812351T1 (sl) Farmacevtski sestavek za zdravljenje multiple skleroze
ZA201407866B (en) Composition for the prevention and treatment of viral infections caused by retroviruses
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds